Conference Evaluation and Certificate of Attendance Request Process
A Certificate of Attendance will be available at the conclusion of the conference. To complete the post-conference materials please go to: www.optumhealtheducation.com/scca2012-evaluation
About This Conference
This two-day multidisciplinary conference will highlight the latest updates in science and clinical practice for oncology, hematology and blood/marrow transplantation. A panel of experts will discuss the most recent clinical innovations and emerging therapies in their respective fields. The goal is to provide attendees with a greater understanding of the advancements and clinical research in the field of oncology to ensure they are providing the best possible adult and pediatric patient care.
Physicians and allied health care professionals—including nurses and case managers—who care for and/or manage benefits for oncology, hematology, and blood/marrow transplant patients will find this conference of great value in continuing their education and helping improve their management of and care provided for this patient population.
Who Should Attend*
- Case Managers
- Hematopoietic Transplant Coordinators
- Managed Care Professionals
- Nurses/Oncology Nurses
- Nurse Practitioners
- Medical Directors
- Medical Management Staff
- Physician Assistants
- Reinsurance Managers
- Utilization Review Staff
- Other Health Care Professionals Committed to Managing and Improving Patient Care
* Refer to the Continuing Education page for a listing of certification that has been applied and/or approved for this conference.
Conference Educational Objectives
Upon successful completion of this conference, participants should be able to:
- State novel techniques for the treatment of cancer and blood disorders and discuss the innovative services that are available for adult and pediatric cancer and blood/marrow transplant (BMT) patients.
- Recognize current treatment trends, indications, and outcomes in oncology and transplantation for pediatrics and adults.
- Describe the latest cancer research that may impact clinical management standards in the future.
- Discuss the role of precision medicine in health care and how to integrate clinical information with physiological, biochemical and molecular laboratory studies to help define individual patterns of disease.
- Explore alternative graft sources for BMT patients who have not found a matching donor and the overall response rates to these treatment methods.